Aspermont Limited (ASX:ASP)

Longboard Pharmaceuticals Revenue

Aspermont had revenue of 6.72M AUD in the half year ending March 31, 2025, a decrease of -28.19%. This brings the company's revenue in the last twelve months to 16.24M, down -9.05% year-over-year. In the fiscal year ending September 30, 2024, Aspermont had annual revenue of 17.49M, down -9.15%.

• Revenue (ttm): 16.24M
• Revenue Growth: -9.05%
• P/S Ratio: 0.77
• Revenue / Employee: 213.67K
• Employees: 76
• Market Cap: 12.57M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2024	17.49M	-1.76M	-9.15%
Sep 30, 2023	19.25M	519.00K	2.77%
Sep 30, 2022	18.73M	2.68M	16.67%
Sep 30, 2021	16.05M	849.00K	5.58%
Sep 30, 2020	15.20M	-1.18M	-7.17%